I’d like to buy these 3 bargains for my Stocks and Shares ISA before the FTSE climbs higher

As the FTSE 100 surges and a host of shares look like ending the week a lot higher, Harvey Jones is going for bargains that have missed a boom.

| More on:
Asian man looking concerned while studying paperwork at his desk in an office

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 has gone on a tear just as the deadline for using this year’s Stocks and Shares ISA allowance looms. So is there still good value out there? Happily, I think there is.

As with any rally, some shares refused to participate. That applies to one of my favourite portfolio holdings, wealth manager M&G (LSE: MNG).

While the FTSE 100 as a whole is up 2.51% over five days, the M&G share price is down 3.82%. However, this follows a strong run, with the share price 20.27% higher than 12 months ago.

Still bargains out there

It’s impossible to discuss M&G without mentioning its blockbuster trailing yield of 8.31%. If that’s sustainable, I’d double my money in less than nine years, even if the share price did not rise.

Investors gave yesterday’s 2023 results a lukewarm response, even though it turned last year’s £2.1bn loss into a £309m IFRS profit after tax. Net client flows, adjusted profits, and operating capital generation all rose.

The board only increased the dividend 0.1p to 19.7p per share, which suggests I may not see much dividend growth in the next few years. Given the high yield, I can live with that. I can happily top up my holding at today’s 2024 valuation of just 10.4 times earnings, without wishing I’d done it a week ago.

I bought a small stake in pharmaceutical firm GSK (LSE: GSK) as a long-term defensive buy and hold in January, and I’ve been wondering whether to buy more. I don’t have to worry about the share price being inflated by the recent rally, it’s down 0.83% over the last week. Over one year it’s up a solid 17.21%.

GSK is still in recovery mode after a bumpy few years, when the company hived off consumer healthcare division Haleon, without finding fresh direction of its own.

I hope they play catch up

Its moment seems to be edging closer, as a growing stream of positive drug trials raise hopes that its pipeline will finally start to replenish. It’s no longer the dividend hero of yore, with a modest trailing yield of just 3.44%, but I’m hopeful that will pick up over time.

Trading at 10.79 times earnings, GSK is still cheap. Developing new treatments is a tricky, long-term process, but I expect GSK to reward my patience over the long run. I’m ready to buy more.

I don’t own shares in FTSE 100-listed pest control specialist Rentokil Initial (LSE: RTO), but I’ve been considering them for months. I missed my chance before full-year results on 7 March showed adjusted pre-tax profit jumping 43.8% to £766m. The share price rocketed almost 15% in a single day.

This helped reverse much of the damage done in November, when Rentokil warned profits were coming in “marginally below” expectations, amid slow growth in the US.

The share price has shunned this week’s excitement to trade 0.5% lower. It does look a little pricey though, trading at 20.54 times earnings, while the yield is a meagre 1.84%. I’ll keep a watching brief on Rentokil. I would like it to be a bit cheaper, to be honest.

That’s not a problem with GSK or M&G, which both look good value to me. I’m keen to buy before they start rising, too.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has positions in GSK and M&g Plc. The Motley Fool UK has recommended GSK, Haleon Plc, M&g Plc, and Prudential Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

Investing freedom — but inside a pension

Strapped consumers might be cutting back on investing, but they’re still keeping up their pension contributions. The only problem? A…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Forget gold! I’d rather buy these 3 FTSE high-yielders in a Stocks and Shares ISA

Gold looks like a risky investment to me as the price hits an all-time high. I'm ignoring the fuss to…

Read more »

Young female business analyst looking at a graph chart while working from home
Growth Shares

This 55p UK stock could rise more than 300%, according to a City broker

This UK stock has fallen from above 800p to below 60p. But analysts at Citi believe it’s capable of a…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

I think this FTSE 250 trust has all the right ingredients to lock in long-term profits

Today I'm examining the prospects of a private equity investment trust on the FTSE 250 that caught my attention recently…

Read more »

Young black man looking at phone while on the London Overground
Investing Articles

2 under-the-radar UK shares investors should consider snapping up

Two UK shares have caught the eye of our writer. She explains why investors should be taking a closer look…

Read more »

Investing Articles

Are these 2 ultra-high-yielding income stocks a good buy for me?

These two income stocks often split the debate amongst investors. So what does our writer think of them as potential…

Read more »

Senior woman potting plant in garden at home
Investing Articles

5% yield! This dividend stock could be great for my retirement

Our writer explains why this dividend stock appeals to her as she’s investing to build wealth to enjoy in the…

Read more »

A young Asian woman holding up her index finger
Investing Articles

I’d aim for a second income of £1,000 a month with this super-reliable dividend stock

I think a great way to build a second income stream is by investing in dividend stocks via a Stocks…

Read more »